| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9954107 | Clinica Chimica Acta | 2018 | 7 Pages |
Abstract
- Comparing presepsin, procalcitonin and CRP in patients with hematologic disorders.
- Only presepsin showed significant diagnostic ability in early phase of febrile events.
- Presepsin is also a useful marker for differential diagnosis of febrile neutropenia.
- Presepsin may be a biomarker for assessing whether initial treatment is effective.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Kazutoshi Ebisawa, Junji Koya, Kumi Nakazaki, Shunya Arai, Fumihiko Nakamura, Mineo Kurokawa,